[en] BACKGROUND: AGM-1470 is a newly synthesized molecule developed as an analog of the potent anti-angiogenic fumagillin. Its efficacy in restraining tumor growth in vivo and the absence of major side effects have already led to phase I clinical trials in patients with solid cancers. However, neither the exact mechanisms of action of AGM-1470 nor its effects on the host of normal cells have been extensively studied. Recently, we showed that AGM-1470 enhanced the proliferation of B lymphocytes in the presence of T cells. Since AGM-1470 could potentially be used in patients with lymphoma, it was urgent to test the effect of the molecule on the proliferation of tumor lymphocytes. METHODS: The possible effect of AGM-1470 on the proliferation of normal or tumor lymphocytes was evaluated by thymidine-incorporated assays. Normal T and B lymphocytes were purified from human tonsils. The tumor lymphocytes used in the study were Molt 3, Molt 4 and Jurkatt cell lines for the T lineage and Daudi and Radji cell lines for the B lineage. RESULTS: As shown previously, AGM-1470 stimulates the proliferation of normal B lymphocytes through an action on normal T cells. THe angioinhibin was ineffective ont eh proliferation of both T and B transformed cells. Moreover, in the presence of the drug, tumor T cells co-cultured with normal B lymphocytes did not induce any increase in B cell proliferation, as previously observed with normal T lymphocytes. Inversely, tumor B cells co-cultured with normal T lymphocytes were insensitive to the drug. CONCLUSIONS: Our results demonstrate that AGM-1470 is ineffective on lymphoid tumor cell proliferation and could potentially be safely administered to lymphoma patients.
Disciplines :
Oncology
Author, co-author :
Antoine, Nadine ; Université de Liège - ULiège > Département de morphologie et pathologie > Histologie
Daukandt, M.
Locigno, R.
Heinen, Ernst ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Histologie humaine
Simar, L. J.
Castronovo, Vincenzo ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie générale et cellulaire
Language :
English
Title :
The Potent Angioinhibin Agm-1470 Stimulates Normal but Not Human Tumoral Lymphocytes
Antoine N., Greimers R., De Roanne C., Kusaka M., Heinen E., Simar L.J., Castronovo V.: AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle. Cancer Res., 54: 2073-2076, 1994.
Antoine N., Bours V., Heinen E., Simar L.J., Castronovo V.: Stimulation of human B lymphocyte proliferation by AGM-1470, a potent inhibitor of angiogenesis. J. Natl. Cane. Inst., 87: 136-139, 1995.
Berger A.E., Dortch K.A., Staite N.D., Mitchell M.A., Evans B.R., Holm M.S.: Modulation of T lymphocyte function by the angiogenesis inhibitor AGM-1470. Agents Actions, 39: 86-88, 1993.
Brem H., Folkman J.: Analysis of experimental antiangiogenic therapy. J. Pediatr. Surg., 28: 41-45, 1993.
Folkman J.: What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
Ingber D., Fujita T., Kishimoto S., Sudo K., Kamaru T., Brem H., Folkman J.: Synthetic analogs of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature, 348: 555-557, 1990.
Kusaka M., Sudo K., Fujita T., Marui S., Itoh F., Ingber D., Folkman J.: Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem. Biophys. Res. Commun., 174: 1070-1076, 1991.
Schoof D.D., Obando J.A., Cusack J.C., Goedegebuure P.S., Brem H., Eberlein J.T.: The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitro. Int. J. Cancer, 55: 630-635, 1993.
Takamiya Y., Friedlander R.M., Brem H., Malick A., Martuza R.L.J.: Inhibition of angiogenesis and growth of human nervesheath tumors by AGM-1470. Neurosurgery, 78: 470-476, 1993.
Weidner N., Semple J.P., Welch W., Folkman J.: Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
Yamaoka M., Yamamoto T., Masaki T., Ikeyama S., Sudo K., Fujita T.: Inhibitor of tumor growth and metastasis of rodent tumors by angiogenesis inhibitor o-(chloroacetyl-carbamoyl) fumagillol (TNP-40; AGM-1470). Cancer Res., 53; 4262-4267, 1993.
Yanase T., Tamaru M., Fujita K., Kodama S., Tanaka K.: Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res., 53: 2566-2570, 1993.